Search
News
Downloads
About
Help
Contact
Entity Details
Primary name
RS17_HUMAN
Entity type
UniProt
Source
Source Link
Details
Accession
P08708
EntryName
RS17_HUMAN
FullName
40S ribosomal protein S17
TaxID
9606
Evidence
evidence at protein level
Length
135
SequenceStatus
complete
DateCreated
1988-01-01
DateModified
2021-06-02
Ontological Relatives
Genes
RPS17
GO terms
Show/Hide Table
GO
Name
GO:0000184
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay
GO:0002181
cytoplasmic translation
GO:0003723
RNA binding
GO:0003735
structural constituent of ribosome
GO:0005654
nucleoplasm
GO:0005829
cytosol
GO:0005840
ribosome
GO:0005925
focal adhesion
GO:0006364
rRNA processing
GO:0006412
translation
GO:0006413
translational initiation
GO:0006614
SRP-dependent cotranslational protein targeting to membrane
GO:0016020
membrane
GO:0019083
viral transcription
GO:0022626
cytosolic ribosome
GO:0022627
cytosolic small ribosomal subunit
GO:0034101
erythrocyte homeostasis
GO:0042274
ribosomal small subunit biogenesis
Subcellular Location
Show/Hide Table
Domains
Show/Hide Table
Domain
Name
Category
Type
IPR001210
Ribosomal protein S17e
Family
Family
IPR018273
Ribosomal protein S17e, conserved site
Site
Conserved site
IPR036401
Ribosomal protein S17e-like superfamily
Family
Homologous superfamily
Diseases
Show/Hide Table
Drugs
Show/Hide Table
Drug
Name
Source
Type
DB11638
Artenimol
Drugbank
small molecule
Interactions
10 interactions
Interactor
Partner
Sources
Publications
Link
RS17_HUMAN
UB2D1_HUMAN
IntAct
19549727
details
RS17_HUMAN
UB2D2_HUMAN
IntAct
19549727
details
RS17_HUMAN
CAC1A_HUMAN
BioGRID, IntAct
21078624
details
RS17_HUMAN
DUX4_HUMAN
BioGRID, IntAct
26816005
details
RS17_HUMAN
RS4X_HUMAN
BioGRID
22939629
6188845
details
RS17_HUMAN
PTEN_HUMAN
BioGRID
26561776
details
RS17_HUMAN
M3K14_HUMAN
IntAct
14743216
details
RS17_HUMAN
FOS_HUMAN
IntAct
20195357
details
RS17_HUMAN
KAP0_HUMAN
IntAct
20195357
details
RS17_HUMAN
SOX2_HUMAN
BioGRID
21280222
details
This website requires cookies in order to function. By using the site you are agreeing to this as outlined in our
Terms of Use
I Agree